Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Rubicon Genomics Adds European Distributors Ahead of New Product Launches

Published: Saturday, June 14, 2014
Last Updated: Saturday, June 14, 2014
Bookmark and Share
Company has signed agreements with seven distributors to expand the availability of its DNA library preparation products.

Rubicon Genomics, Inc. has announced that it has signed agreements with seven distributors in Europe to expand the availability of its leading DNA library preparation products, including ThruPLEX®-FD Prep Kit and PicoPLEX™ DNA-seq Kit for use with Illumina® next-generation sequencing (NGS) systems and PicoPLEX™ WGA Kit for use on arrays, and to prepare for new product launches planned for the coming months.

The new distributors include Cambridge Bioscience in the UK and Ireland, Biozym Scientific GmbH in Germany and Austria, AB ANALITICA in Italy, Sopachem in the Benelux countries, Nordic Biolabs in Denmark and Sweden, Immuno Diagnostic Oy in Finland and YBUX inRomania, the Slovak Republic and the Czech Republic.

James Koziarz, PhD, CEO of Rubicon Genomics, commented, “Our healthy increase in revenues during the past year reflects the early stages of our strategic efforts to aggressively expand our product offerings and build a network of first-rate distributors around the globe. Now that we have our key distribution channels in place, we expect to achieve even greater sales growth going forward, through broader distribution of our recently launched products and the addition of product enhancements in the coming months.”

During the second quarter, Rubicon will launch ThruPLEX DNA-seq 48D kits and ThruPLEX DNA-seq 96D kits. These enhancements of the company’s ThruPLEX FD Prep kits DNA-seq product line offer an increased number of barcodes, which will enable scientists to use ThruPLEX DNA-seq kits for high throughput applications, and reformulated chemistries that provide improved performance. These kits are currently undergoing Beta testing worldwide with samples ranging from cell-free (cf) plasma DNA to human oocyte cDNA, and initial response has been excellent.

The enhanced ThruPLEX DNA-seq products address the needs of clinicians and scientists working in high throughput applications by adding either 48 or 96 dual barcodes to the kit. The chemistry has also been reformulated and demonstrates improved performance that is especially helpful for challenging clinical specimens, such as plasma or FFPE samples, where DNA input amounts are typically low and/or damaged.

ThruPLEX DNA-seq kits streamline library preparation for DNA/cDNA and reduce sample input amounts to picogram levels. The ThruPLEX DNA-seq kit’s patented technology delivers a highly-efficient and user-friendly three-step process that takes place in a single tube in less than two hours, eliminating purifications and speeding time to results. ThruPLEX DNA-seq provides accurate and reproducible results for a variety of applications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rubicon Genomics Raises $2M
Rubicon Genomics today announced it has secured $2 million in growth capital financing.
Thursday, July 16, 2015
Rubicon Genomics Adds Global Distributors
Sales of Rubicon Genomics’ DNA library prep kit products increase over 50% as expansion of distribution channels continues.
Friday, October 17, 2014
Rubicon Partners with Diagenode for ChIP Sample Preparation
Combining Rubicon ThruPLEX™ and Diagenode technologies enables scientists to efficiently conduct high quality ChIP studies from small samples for NGS and array analysis.
Monday, November 05, 2012
New Data Show Rubicon’s Amplification Technology Enables Genetic and Epigenetic Analyses of Single Cells Using Next-Gen Sequencing
Data show Rubicon’s whole genome and whole Methylome Amplification kits offer key advantages for cancer, stem cell, and embryo studies.
Tuesday, November 02, 2010
Rubicon Genomics’ PicoPlex™ Technology Enables International Clinical Genetic Study of Single Human Cells
PicoPlex technology validated for accurate testing of single human cells to diagnose genetic abnormalities in advance of assisted reproduction.
Thursday, July 01, 2010
bicon Genomics, Inc. Creates Scientific Advisory Board

Friday, May 31, 2002
Rubicon Genomics, Inc. Creates Scientific Advisory Board

Friday, May 31, 2002
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos